Tasmolin



Indications and Reactions:

Role Indications Reactions
Primary
Drug Use For Unknown Indication 81.3%
Schizophrenia 18.8%
Urinary Retention 100.0%
Secondary
Schizophrenia 41.5%
Drug Use For Unknown Indication 10.8%
Depression 10.3%
Schizophrenia, Paranoid Type 8.5%
Product Used For Unknown Indication 5.8%
Prophylaxis 4.0%
Analgesic Therapy 3.0%
Parkinsonism 2.8%
Anxiety 2.3%
Operative Haemorrhage 2.0%
Constipation 1.0%
Diabetes Mellitus 1.0%
General Anaesthesia 1.0%
Hypercholesterolaemia 1.0%
Hypotonia 1.0%
Sedative Therapy 1.0%
Shock 1.0%
Partial Seizures 0.8%
Psychiatric Symptom 0.8%
Ill-defined Disorder 0.5%
Urinary Retention 35.7%
Parkinsonism 9.5%
Cardiac Failure 7.1%
Coma 7.1%
Death 7.1%
Platelet Count Increased 7.1%
Treatment Noncompliance 7.1%
Overdose 4.8%
Suicide Attempt 4.8%
Gait Disturbance 2.4%
Hepatic Function Abnormal 2.4%
Rhabdomyolysis 2.4%
Shock 2.4%
Concomitant
Schizophrenia 46.3%
Product Used For Unknown Indication 6.9%
Insomnia 6.1%
Bipolar Disorder 4.0%
Akathisia 3.9%
Schizophrenia, Paranoid Type 3.6%
Extrapyramidal Disorder 3.5%
Depression 3.1%
Constipation 2.6%
Drug Use For Unknown Indication 2.4%
Paranoia 2.1%
Parkinsonism 2.1%
Diabetes Mellitus 1.9%
Nausea 1.9%
Prophylaxis 1.9%
Epilepsy 1.8%
Parkinson's Disease 1.8%
Schizophrenia, Undifferentiated Type 1.7%
Hypertension 1.4%
Mania 1.2%
Psychiatric Symptom 18.8%
Schizophrenia 11.6%
Hepatic Function Abnormal 7.1%
Pneumonia 7.1%
Fall 6.3%
Pancytopenia 5.4%
Pulmonary Oedema 5.4%
White Blood Cell Count Increased 5.4%
Completed Suicide 3.6%
Pneumonia Aspiration 3.6%
Restlessness 3.6%
Weight Decreased 3.6%
Drug Rash With Eosinophilia And Systemic Symptoms 2.7%
Myalgia 2.7%
Neuroleptic Malignant Syndrome 2.7%
Pregnancy 2.7%
Vomiting 2.7%
Blood Creatine Phosphokinase Increased 1.8%
Blood Glucose Increased 1.8%
Blood Lactate Dehydrogenase Increased 1.8%